Thema
Journal Article
8
Antirheumatic Agents
7
Review
7
tuberculosis
5
LTBI
4
Tumor Necrosis Factor-alpha
4
psoriatic arthritis
4
rheumatoid arthritis
4
Systematic Review
3
Anti-JAKs
2
Biologic therapy
2
Biological Products
2
Biologics
2
JAK-inhibitors
2
Meta-Analysis
2
TB risk
2
anti-TNF drugs
2
comorbidities
2
csDMARDs
2
drug safety
2
extra-articular manifestations
2
infection
2
interleukin-12
2
interleukin-23
2
meta-analysis
2
non-anti-TNF biologics
2
quantiferon
2
rheumatic disease
2
systematic review
2
tailored therapy
2
ustekinumab
2
187348-17-0
1
Adverse events
1
Ankylosing spondylitis
1
Anti-TNF agents
1
Anti-drug antibodies
1
Antibodies
1
Dermatologic Agents
1
FU77B4U5Z0
1
Immunologic Factors
1
Interleukin-12
1
Interleukin-17
1
Interleukin-23
1
Janus Kinase Inhibitors
1
TNF-alpha
1
Tumor Necrosis Factor Inhibitors
1
Ustekinumab
1
ankylosing spondylitis
1
anti-TNF agents
1
cancer
1
mehr ...